Radio and PodcastRadio and PodcastLive Radio & Podcasts
Ep190: Neil Kumar on Building a Rare Disease Drug Company artwork
Science & Medicine

Ep190: Neil Kumar on Building a Rare Disease Drug Company

The Long Run with Luke Timmerman by The Long Run with Luke Timmerman

Nov 20, 202501:13:12Science & Medicine

Neil Kumar is founder and CEO of Palo Alto, Calif.-based BridgeBio Pharma, a rare disease drug developer.

Related Episodes

Continue listening to more episodes from The Long Run with Luke Timmerman.